Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | FBRX | PBYI | ||
| Company | Cellectis S.A. ADR | Forte Biosciences Inc | Puma Biotechnology | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.94 | 27.41 | 7.44 | ||
| High | 3.99 | 28.30 | 7.70 | ||
| Low | 3.81 | 26.33 | 7.39 | ||
| Latest | 3.95 | 26.52 | 7.45 | ||
| Change | +0.19 | -0.77 | +0.10 | ||
| % Change | +5.05% | -2.82% | +1.36% | ||
| Volume | 17,600 | 109,000 | 484,400 | ||
| 20-Day Average Volume | 35,600 | 403,045 | 266,370 | ||
| Previous Close | 3.76 | 27.29 | 7.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.96 | 30.02 | 7.49 | ||
| 20-Day Raw Stochastic | 45.46% | 5.11% | 44.65% | ||
| 20-Day Relative Strength | 52.83 | 45.86 | 56.91 | ||
| Weighted Alpha | +81.85 | +68.19 | +95.90 | ||
| Today's Opinion | 24% Buy | 32% Buy | 88% Buy | ||
| Previous Opinion | 8% Buy | 32% Buy | 88% Buy | ||
| Last Month's Opinion | 72% Sell | 56% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.90% since 04/29/26 | -5.39% since 04/29/26 | -0.40% since 04/29/26 | ||
| Low | 3.66 on 05/04/26 | 26.10 on 05/01/26 | 7.11 on 05/05/26 | ||
| High | 4.04 on 05/01/26 | 30.41 on 05/04/26 | 7.70 on 05/05/26 | ||
| 1-Month | |||||
| %Chg | +14.83% since 04/06/26 | +0.30% since 04/06/26 | +8.13% since 04/06/26 | ||
| Low | 3.30 on 04/07/26 | 25.09 on 04/08/26 | 6.61 on 04/07/26 | ||
| High | 4.55 on 04/13/26 | 35.80 on 04/09/26 | 7.90 on 04/10/26 | ||
| 3-Month | |||||
| %Chg | +10.64% since 02/06/26 | -3.88% since 02/06/26 | +7.35% since 02/06/26 | ||
| Low | 2.99 on 03/31/26 | 22.01 on 03/20/26 | 5.50 on 03/02/26 | ||
| High | 4.55 on 04/13/26 | 35.80 on 04/09/26 | 7.90 on 04/10/26 | ||
| 6-Month | |||||
| %Chg | +26.20% since 11/06/25 | +131.92% since 11/06/25 | +52.04% since 11/06/25 | ||
| Low | 2.99 on 03/31/26 | 11.04 on 11/07/25 | 4.57 on 11/11/25 | ||
| High | 5.45 on 12/11/25 | 35.80 on 04/09/26 | 7.90 on 04/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 377,275 | 378,949 | 374,056 | ||
| Shares Outstanding, K | 100,339 | 13,886 | 50,892 | ||
| Annual Sales | 79,590,000 | 0 | 228,370,000 | ||
| Annual Net Income | -67,590,000 | -69,380,000 | 31,110,000 | ||
| Last Quarter Sales | 12,210,000 | 0 | 75,450,000 | ||
| Last Quarter Net Income | -26,320,000 | -24,790,000 | 13,440,000 | ||
| 60-Month Beta | 2.94 | 3.01 | 1.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 03/19/26 | -1.45 on 03/31/26 | 0.29 on 02/26/26 | ||
| Earnings Date | 05/11/26 | 05/21/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 12.34 | ||